• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neurocognitive and Resting-State Functional Magnetic Resonance Imaging Changes in Patients With Diffuse Gliomas After Chemoradiation Therapy.弥漫性胶质瘤患者放化疗后神经认知及静息态功能磁共振成像变化
Int J Radiat Oncol Biol Phys. 2025 Sep 1;123(1):93-106. doi: 10.1016/j.ijrobp.2025.03.017. Epub 2025 Mar 17.
2
Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma.动态磁敏感对比灌注 MRI 衍生的假性静息态功能 MRI 可预测脑肿瘤患者认知障碍。
AJNR Am J Neuroradiol. 2024 Oct 3;45(10):1552-1561. doi: 10.3174/ajnr.A8327.
3
Cortical nonenhancing tumor infiltration: a predictive imaging biomarker for IDH-mutant glioma.皮质无强化肿瘤浸润:IDH 突变型胶质瘤的一种预测性影像生物标志物。
J Neurosurg. 2025 Apr 4;143(2):340-351. doi: 10.3171/2024.11.JNS242017. Print 2025 Aug 1.
4
Deep learning-based quantification of T2-FLAIR mismatch sign: extending IDH mutation prediction in adult-type diffuse lower-grade glioma.基于深度学习的T2-FLAIR错配征定量分析:扩展成人型弥漫性低级别胶质瘤中异柠檬酸脱氢酶(IDH)突变预测
Eur Radiol. 2025 Mar 7. doi: 10.1007/s00330-025-11475-7.
5
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with -Mutant Glioma.将编辑后的磁共振波谱分析纳入临床实践可能会改善携带突变的胶质瘤患者的护理。
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):113-120. doi: 10.3174/ajnr.A8413.
6
A series of 309 awake surgeries with transcortical approach for IDH-mutant low-grade glioma involving the insula: long-term onco-functional outcomes in 253 consecutive patients.309例采用经皮质入路治疗累及岛叶的异柠檬酸脱氢酶(IDH)突变型低级别胶质瘤的清醒手术:253例连续患者的长期肿瘤功能学结果
J Neurosurg. 2025 Apr 18:1-8. doi: 10.3171/2025.1.JNS242462.
7
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
8
Predicting p53 Status in IDH-Mutant Gliomas Using MRI-Based Radiomic Model.使用基于MRI的放射组学模型预测IDH突变型胶质瘤中的p53状态
Cancer Med. 2025 Aug;14(15):e71063. doi: 10.1002/cam4.71063.
9
An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.对170例胶质瘤患者进行分析并进行系统评价,以研究异柠檬酸脱氢酶-1(IDH-1)突变与术前胶质瘤相关癫痫之间的关联。
J Clin Neurosci. 2016 Sep;31:56-62. doi: 10.1016/j.jocn.2015.11.030. Epub 2016 Jul 9.
10
Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis.成人低级别胶质瘤患者 T2-FLAIR 不匹配征象与 IDH 突变状态的放射基因组关联:一项更新的系统评价和荟萃分析。
Eur Radiol. 2022 Aug;32(8):5339-5352. doi: 10.1007/s00330-022-08607-8. Epub 2022 Feb 15.

本文引用的文献

1
Optimal approaches to analyzing functional MRI data in glioma patients.分析脑胶质瘤患者功能磁共振成像数据的最佳方法。
J Neurosci Methods. 2024 Feb;402:110011. doi: 10.1016/j.jneumeth.2023.110011. Epub 2023 Nov 18.
2
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.美国 2016-2020 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2023 Oct 4;25(12 Suppl 2):iv1-iv99. doi: 10.1093/neuonc/noad149.
3
Functional network disorganization and cognitive decline following fractionated whole-brain radiation in mice.分阶段全脑放射后小鼠的功能网络紊乱与认知能力下降。
Geroscience. 2024 Feb;46(1):543-562. doi: 10.1007/s11357-023-00944-w. Epub 2023 Sep 25.
4
Glioblastoma induces whole-brain spectral change in resting state fMRI: Associations with clinical comorbidities and overall survival.胶质母细胞瘤在静息状态 fMRI 中诱导全脑光谱变化:与临床合并症和总生存期的相关性。
Neuroimage Clin. 2023;39:103476. doi: 10.1016/j.nicl.2023.103476. Epub 2023 Jul 13.
5
Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis.成人脑胶质瘤患者多模态治疗后的认知结果:一项荟萃分析。
Neuro Oncol. 2023 Aug 3;25(8):1395-1414. doi: 10.1093/neuonc/noad045.
6
Mid-term treatment-related cognitive sequelae in glioma patients.胶质瘤患者的中期治疗相关认知后遗症。
J Neurooncol. 2022 Aug;159(1):65-79. doi: 10.1007/s11060-022-04044-1. Epub 2022 Jul 7.
7
Resting-state functional MRI language network connectivity differences in patients with brain tumors: exploration of the cerebellum and contralesional hemisphere.静息态功能磁共振成像语言网络连接在脑肿瘤患者中的差异:对小脑和对侧半球的探索。
Brain Imaging Behav. 2022 Feb;16(1):252-262. doi: 10.1007/s11682-021-00498-5. Epub 2021 Aug 1.
8
Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.生活质量与脑肿瘤患者的神经认知功能独立相关:一项前瞻性临床试验分析。
Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):754-763. doi: 10.1016/j.ijrobp.2021.05.134. Epub 2021 Jun 6.
9
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.辅助和同步替莫唑胺治疗1p/19q未共缺失的间变性胶质瘤(CATNON;欧洲癌症研究与治疗组织26053-22054研究):一项随机、开放标签的3期研究的第二次中期分析
Lancet Oncol. 2021 Jun;22(6):813-823. doi: 10.1016/S1470-2045(21)00090-5. Epub 2021 May 14.
10
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).一项贝伐珠单抗治疗新诊断胶质母细胞瘤的随机试验(NRG/RTOG 0825)的神经认知、症状和健康相关生活质量结局。
Neuro Oncol. 2021 Jul 1;23(7):1125-1138. doi: 10.1093/neuonc/noab011.

弥漫性胶质瘤患者放化疗后神经认知及静息态功能磁共振成像变化

Neurocognitive and Resting-State Functional Magnetic Resonance Imaging Changes in Patients With Diffuse Gliomas After Chemoradiation Therapy.

作者信息

Liu Zhihua, Mitchell Timothy J, Luo Chongliang, Park Ki Yun, Shimony Joshua S, Fucetola Robert, Leuthardt Eric C, Perkins Stephanie M, Snyder Abraham Z, Zhu Tong, Huang Jiayi

机构信息

Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri.

Division of Public Health Sciences, Washington University School of Medicine, St Louis, Missouri.

出版信息

Int J Radiat Oncol Biol Phys. 2025 Sep 1;123(1):93-106. doi: 10.1016/j.ijrobp.2025.03.017. Epub 2025 Mar 17.

DOI:10.1016/j.ijrobp.2025.03.017
PMID:40107623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12404197/
Abstract

PURPOSE

This prospective observational study employed resting-state functional magnetic resonance imaging (rs-fMRI) to investigate network-level disturbances associated with neurocognitive function (NCF) changes in patients with gliomas following partial-brain radiation therapy (RT).

METHODS AND MATERIALS

Adult postoperative patients with either isocitrate dehydrogenase (IDH)-wild-type or IDH-mutant gliomas underwent computerized NCF testing and rs-fMRI at baseline and 6 months post-RT. rs-fMRI data were assessed using seed-based functional connectivity (FC). NCF changes were quantified by the percent change in age-normalized composite scores from baseline (ΔNCF). Connectivity regression analysis assessed the association between network FC changes and NCF changes, using a split-sample approach with a 26-patient training set and a 6-patient validation set, iterated 200 times. Permutation tests evaluated the significance of network selection.

RESULTS

Between September 2020 and December 2023, 43 patients were enrolled, with 32 completing both baseline and follow-up evaluations. The mean ΔNCF was 2.9% (SD, 13.7%), with 38% experiencing a decline. Patients with IDH-mutant glioma had similar NCF changes compared with those with IDH-wild-type glioma. Intrahemispheric FC was similar between ipsilateral and contralateral hemispheres for 91% of patients at baseline, and 69% had similar intrahemispheric FC change posttreatment. FC changes accounted for a moderate fraction of variance in NCF changes (mean R, 0.301; SD, 0.249), with intranetwork FC of the parietal memory network (PMN-PMN, P = .001) and internetwork FC between the PMN and the visual network (PMN-VN, P = .002) as the most significant factors. Similar findings were obtained by sensitivity analyses using only the FC data from the hemisphere contralateral to the tumor.

CONCLUSIONS

Post-RT rs-fMRI changes significantly reflected NCF decline, highlighting rs-fMRI as a promising imaging biomarker for neurocognitive decline after RT.

摘要

目的

本前瞻性观察性研究采用静息态功能磁共振成像(rs-fMRI)来探究部分脑放射治疗(RT)后胶质瘤患者中与神经认知功能(NCF)变化相关的网络水平干扰。

方法和材料

成年术后异柠檬酸脱氢酶(IDH)野生型或IDH突变型胶质瘤患者在基线期和放疗后6个月接受计算机化NCF测试和rs-fMRI检查。rs-fMRI数据使用基于种子的功能连接(FC)进行评估。NCF变化通过与基线期年龄标准化综合评分的百分比变化(ΔNCF)进行量化。连接性回归分析使用包含26例患者的训练集和6例患者的验证集的拆分样本方法评估网络FC变化与NCF变化之间的关联,重复200次。置换检验评估网络选择的显著性。

结果

2020年9月至2023年12月期间,共纳入43例患者,其中32例完成了基线期和随访评估。平均ΔNCF为2.9%(标准差,13.7%),38%的患者出现下降。IDH突变型胶质瘤患者与IDH野生型胶质瘤患者的NCF变化相似。91%的患者在基线期同侧和对侧半球的半球内FC相似,69%的患者在治疗后半球内FC变化相似。FC变化在NCF变化中占中等比例的方差(平均R,0.301;标准差,0.249),顶叶记忆网络的网络内FC(PMN-PMN,P = .001)以及PMN与视觉网络之间的网络间FC(PMN-VN,P = .002)为最显著因素。仅使用肿瘤对侧半球的FC数据进行敏感性分析也获得了相似结果。

结论

放疗后rs-fMRI变化显著反映了NCF下降,突出了rs-fMRI作为放疗后神经认知下降的一种有前景的成像生物标志物。